Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-17

FDA Approved: LEVETIRACETAM — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for levetiracetam from Fresenius Kabi USA, LLC. The approval covers a change to an already approved product under an Abb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)